73 FR 78 pg. 21630 - Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Addressing Barriers to Diagnosis and Genetic Testing for Duchenne Muscular Dystrophy, Potential Extramural Projects (PEP) 2008-R-12
Type: NOTICEVolume: 73Number: 78Page: 21630
FR document: [FR Doc. E8-8643 Filed 4-21-08; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Addressing Barriers to Diagnosis and Genetic Testing for Duchenne Muscular Dystrophy, Potential Extramural Projects (PEP) 2008-R-12
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.
Time and Date: 1 p.m.-2 p.m., May 16, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review, discussion, and evaluation of "Addressing Barriers to Diagnosis and Genetic Testing for Duchenne Muscular Dystrophy, PEP 2008-R-12."
Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498-1194.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E8-8643 Filed 4-21-08; 8:45 am]
BILLING CODE 4163-18-P